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In vitro engineering of human 3D
chondrosarcoma: a preclinical model relevant for
investigations of radiation quality impact
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Abstract
Background: The benefit of better ballistic and higher efficiency of carbon ions for cancer treatment (hadron-therapy)
is asserted since decades, especially for unresectable or resistant tumors like sarcomas. However, hadron-therapy with
carbon ions stays underused and raises some concerns about potential side effects for patients. Chondrosarcoma is a
cartilaginous tumor, chemo- and radiation-resistant, that lacks reference models for basic and pre-clinical studies in
radiation-biology. Most studies about cellular effects of ionizing radiation, including hadrons, were performed under
growth conditions dramatically different from human homeostasis. Tridimensional in vitro models are a fair alternative
to animal models to approach tissue and tumors microenvironment.
Methods: By using a collagen matrix, standardized culture conditions, physiological oxygen tension and a well defined
chondrosarcoma cell line, we developed a pertinent in vitro 3D model for hadron-biology studies. Low- and high-Linear
Energy Transfer (LET) ionizing radiations from GANIL facilities of ~1 keV/μm and 103 ± 4 keV/μm were used respectively,
at 2 Gy single dose. The impact of radiation quality on chondrosarcoma cells cultivated in 3D was analyzed on cell
death, cell proliferation and DNA repair.
Results: A fair distribution of chondrosarcoma cells was observed in the whole 3D scaffold. Moreover, LET distribution
in depth, for ions, was calculated and found acceptable for radiation-biology studies using this kind of scaffold. No
difference in cell toxicity was observed between low- and high-LET radiations but a higher rate of proliferation was
displayed following high-LET irradiation. Furthermore, 3D models presented a higher and longer induction of H2AX
phosphorylation after 2 Gy of high-LET compared to low-LET radiations.
Conclusions: The presented results show the feasibility and usefulness of our 3D chondrosarcoma model in the study
of the impact of radiation quality on cell fate. The observed changes in our tissue-like model after ionizing radiation
exposure may explain some discrepancies between radiation-biology studies and clinical data.
Background
Emerging protocols of radiation-therapy (RT) with
charged particles (protons or heavier ions than helium
ions), in advanced medical facilities have widely changed
the way of thinking about local tumor control and im-
pact on healthy tissues. Indeed, charged particle-therapy
(hadron-therapy) has the advantage of an excellent beam
ballistic and a minimal exit dose after energy deposition
in the target volume, and hence better sparing of critical
structures in the vicinity of the tumor [1]. Unlike pho-
tons, protons and heavy ions exhibit a depth-dose distri-
bution profile characterized by the Bragg peak, a sharp
rise in energy deposition at the end of their range with a
steep dose falloff downstream. However, the ratio of dose
at the Bragg peak to that in the entrance region is higher
for heavy ions [2]. Furthermore, compared to photons and
protons, heavy ions have a higher Linear Energy Transfer
(LET). Because high-LET radiation is densely ionizing, the
correlated DNA damages within one cell occur more often
so that it becomes more difficult for the cell to repair the
damage, leading to a markedly increased efficiency of cell
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killing. In addition, heavy ions have less dependency on
cell cycle and oxygen tension. Indeed, a particle beam
with a high-LET (LET ~100 +/− 20 keV/μm) is required
to meet an optimal biological effectiveness [1]. Thus,
RT with heavy ions such as carbon ions represents an
attractive radiation modality, which combines the phys-
ical advantages of protons, with a higher radiobiological
effectiveness. Thanks to such improved biological ef-
fectiveness, these technologies are expected to reduce
frequency and severity of radiation morbidity. However,
the tremendous amount of combination of radiation
quality (LET, energy, dose rate, dose) and tissue bio-
logical status (co-morbidity factors, genetic background,
O2 tension) does not simplify the building of a relevant
model for exposure of healthy tissues or tumors during
RT [3]. Therefore, it is necessary to develop new tools
in order to optimize the use of hadron beams in cancer
therapy either in the development of new instruments
for beam control and dosimetry or in the understanding
of the biological effects of hadrons on healthy tissue and
various kinds of tumor.
Chondrosarcoma (CHS) is a malignant skeletal tumor
with cartilaginous differentiation (dissimilar from other
primary skeletal tumors) and represents the second
most common primary bone tumor in adults, generally
arising in the fourth decade. It is a heterogeneous
group of tumors that have in common the production
of chondroid matrix. Conventional CHS subgroup rep-
resents ~ 85 % of total cases and can be subdivided in
low-grade (I), intermediate-grade (II) or high-grade
(III) based on histology [4]. Primary treatment is surgi-
cal but, due to the location of tumors close to critical
structures (abdomen, cranial and spinal nerves), the
complete resection is rarely possible. Indeed, CHS is
considered as a chemo- and radiation-resistant cancer,
needing high dose RT in inoperable or incompletely
resected tumors [2]. Hadron-therapy has been applied to
the treatment of low- and intermediate-grade CHS at dif-
ferent locations, with very promising results [2, 5, 6]. How-
ever, prospective randomized trials comparing different RT
modalities are still needed to validate the superiority of one
treatment for a given indication. The understanding of the
impact of low- versus high-LET beams on normal and
tumor tissues is, then, important to enhance the know-
ledge and serve clinical use of hadrons.
To date, most current CHS animal models consist in the
subcutaneous xenografting of CHS cell lines or human
tumor tissue [7]. Three orthotopic CHS mouse models
were published recently [8–10] using CHS human cell
lines, but there is no transgenic mouse model for this dis-
ease. Considering the lack of radiation-biology studies on
CHS, in contrast with the existence of a subset of medical
data confirming the effectiveness of hadrons, and the ab-
sence of an in vivo reference model, we developed a new
CHS three-dimensional (3D) model in order to mimic in
vivo microenvironment. Indeed, over the past sixty years,
two-dimensional monolayer cells (2D) cultured in atmos-
pheric oxygen tension (20 % O2, referred as normoxia)
have been considered as a gold standard in cell biology
and more specifically in radiation-biology studies. How-
ever, the 3D environment [11] and oxygen tension [12]
have a major impact on cellular response to ionizing radia-
tions (IRs). Basic 3D cultures of CHS cells have been pre-
viously used for drug testing but chondrogenic properties
of type I/III collagen [13], and physioxic culture conditions
were not taken into account as demonstrated previously
[14, 15]. Indeed, in a previous study, P. Galera’s team pro-
posed a new 3D cartilage model (3DCaM), relevant for
arthritis analysis [15]. They used a 3D scaffold composed
of cross-linked type -I and -III collagen, and successfully
handled this matrix with Articular Chondrocytes (AC),
isolated from human donors. As compared with conven-
tional in vitro 2D culture, they showed the advantages of
this 3D scaffold, in association with chondrogenic factors
and physiological oxygen tension (2 % O2, referred as phy-
sioxia), to allow cell re-differentiation and natural cartilage
matrix synthesis. It should be noted that cartilage is the
only avascular tissue of human body explaining the low
O2 tension of this tissue [16, 17].
Using the most characterized grade II CHS cell line
(SW1353), a standardized chondrocyte medium, a chon-
drogenic factor (BMP-2), physiological oxygen tension
(2 % O2) and the same collagen scaffold [15, 18], we report
here the first 3D CHS model (3DCM) applied to
radiation-biology studies. We used two different IRs; ac-
celerated 18O ion beam as a high-LET radiation, compar-
able to the LET of carbon ions beam delivered into the
tumor volume (Spread-Out Bragg Peak, SOBP) during
hadron-therapy [19], and X-rays as a low-LET radiation
(control). We used a single 2 Gy dose and LET distribu-
tion profile of ions was calculated in order to ascertain a
homogenous irradiation of 3DCM. Radiation-induced cell
death was assessed with our 3DCM and canonical clono-
genic assay in 2D culture as a reference. Ki67 proliferation
index and gamma-H2AX kinetic were carried out to dem-
onstrate the feasibility and the proof of usefulness of
3DCM in hadron-biology and the impact of radiation
quality on proliferation and DNA double strand breaks
(DSBs) repair.
Methods
Reagents and antibodies
SW1353 CHS cell line, human Articular Chondrocytes
(AC) and the following culture media were purchased from
CellSystems (Troisdorf, Germany); Chondrocyte Growth
Medium w/o Phenol Red (#411PR-500), Chondrocyte
Basal Medium w/o Phenol Red w/o FBS (#410PR-500) and
Chondrocyte Growth Medium w/o Phenol Red w/o FBS
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(#411FPR-500). Collagen scaffolds were bought from
Symatese Biomateriaux (Chaponost, France), BMP-2 (Bone
Morphogenic Protein-2) from R&D Systems (Minneapolis,
USA), Toxilight™ assay from Lonza (Basel, Switzerland),
Digitonin from Promega (Madison, USA), T-PER (Tissue
Protein Extraction Reagent), Halt Protease Inhibitors Cock-
tail 100 X, Halt Phosphatase Inhibitors single-use Cocktail
100 X, anti-GAPDH (#11335232), anti-rabbit HRP-coupled
(#31460) and anti-mouse HRP-coupled (#31430) antibodies
from Thermoscientific (Waltham, USA), anti-H2AX phos-
phoserine 139 (#05-636) and anti-Ki67 (#AB9260) anti-
bodies, ECL classico/crescendo and Accutase™ from Merck
Millipore (Darmstadt, Germany), DAB (Diaminobenzidine)
from Life technologies (Carlsbad, USA).
Cell cultures
All the data reported in this manuscript have been col-
lected from commercially available human healthy chon-
drocytes and CHS cells used in compliance with the
Helsinki Declaration. CellSystems Company (Troisdorf,
Germany) and its supplier, Cell Applications Company
(San Diego, USA), follow bioethics guidelines to comply
with the Helsinki Declaration.
The use of human cells by our Institute and Labora-
tory was approved by the French Ministry of Research
under the CODECOH reference: DC-2008-228.
From Dulbecco's Modified Eagle's Medium (DMEM)
supplemented with 2 mM L-glutamine, 10 % FBS and
antibiotics (100 U/mL of penicillin V, 100 μg/mL of
streptomycin), cells were gradually adapted to a standard-
ized Chondrocyte Growth Medium (#411PR-500). Cells
were checked for Mycoplasma contamination and aliquots
frozen for further experiments. During cell expansion
(2D culture), cells were seeded at 1.3 × 104 cells/cm2
in 75 cm2 culture flasks and maintained at 37 °C in a
humid atmosphere (95 % air, 5 % CO2). Instead of
trypsin, Accutase™ was used as a cell detachment re-
agent. SW1353 were passaged twice a week, not more
than ten times.
For 3D experiments, SW1353 cells were grown in
collagen scaffolds (Fig. 1) as described previously for
Articular Chondrocytes (AC) [15, 18]. These scaffolds
were prepared by Symatese Biomatériaux (Chaponost,
France) and are composed of native type I collagen
(90–95 %) and type III collagen (5–10 %) from calf skin.
They were cross-linked using glutaraldehyde to in-
crease their stability and sterilized with γ-irradiation
[18, 20]. They were punched with a skin biopsy punch
(Laboratoires Stiefel, France) as discs of 5 mm diameter
and 2 mm thickness (which corresponds to a volume of
0.04 cm3). Their pore size is around 100 nm [18].
P. Galera’s team model was adapted for radiation-biology
experiments but instead of DMEM, we used a 3D Chon-
drocyte Medium (#411FPR-500) supplemented with 2 %
FBS. Briefly, cells were seeded onto the scaffold at 4 × 105
cells/scaffold in 96-well culture plates and incubated at
37 °C and 5 % CO2. One hour later, 100 μL of the previ-
ous medium supplemented with BMP-2 (50 ng/mL)
were added to the well and cells were incubated in phy-
sioxia (2 % O2) in a Heracell™ 150i Tri-Gas Incubator,
for 7 days to obtain a 3DCM. The medium was changed
twice a week.
Cell cycle analysis
Cell cycle distribution analysis was performed in 2D cul-
ture. SW1353 cells were plated at subconfluency in T25
culture flasks then placed in the incubator for 6 h. Cells
were then harvested and centrifuged at 800 rpm for 5 min.
Cell pellet was washed in PBS, fixed in ethanol 75° then
stored at 4 °C until analysis. Briefly, cells were centrifuged
at 2000 rpm for 5 min, and the cell pellet resuspended in
PBS before staining. The remaining pellet was gently resus-
pended in 500 μL DNA Prep Stain and 50 μL DNA Prep
LPR (DNA Prep Reagent kit, Beckman Coulter). Samples
were incubated in the dark for 15 min and a minimum of
1 × 104 cells per sample were analyzed using GALLIOS
flow cytometer (Beckman Coulter, Passadena, USA).
FlowJo analyzing software (Ashland, USA) was used. Ex-
periments were repeated four times and data expressed as
mean ± Standard Error on the Mean (S.E.M.).
Low-LET irradiation
Low-LET radiation exposure was performed, either at
the CLCC (Centre de Lutte Contre le Cancer) François
Baclesse (Caen, France) or at Cyceron facility (Caen,
France). We used respectively, a Saturne 15 (15 MV,
6 mA, Siemens) medical linear accelerator producing X-
rays or an X-RAD 225 Cx (225 kV, 13 mA, PXi) research
X-rays generator intended to cellular and small animal
irradiation. The X-RAD 225 Cx is characterized by a
first half value layer of 0.9 mm of copper. X-rays of
this beam produce low energy secondary electrons
with dE/dX ranging from 0.26 to 2.25 keV/μm with a
mean value of 1.65 keV/μm (instead of 0.2 keV/μm
for MV beams). Absolute dosimetry of the irradiator
was performed following AAPM TG-61 protocol [21]
and the dose delivered to cellular samples was mea-
sured thanks to ionization chamber measurements
and thermo luminescent dosimeters (TLD). Except for
survival curves, the canonical single dose fraction in
conventional radiotherapy of 2 Gy was used for all
experiments at a 2 Gy/min dose rate.
Irradiation of 2D cells was performed as follows:
cells were seeded 48 h prior to irradiation, at a dens-
ity of 2.4 × 104/cm2 in 12.5 cm2 culture flasks (BD
Falcon™), so that they reach subconfluency at the time
of irradiation. One day later, they were incubated in a
Tri-Gas Incubator (2 % O2) for physioxic irradiation
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environment. Immediately prior to irradiation, flasks
were completely filled with 2D Chondrocyte Basal
Medium (#410PR-500) previously balanced with 2 % O2,
and then sealed in order to maintain a constant oxygen
tension. Then, they were placed on a horizontal plate
within the X-ray generator (Fig. 2a). Mock-irradiated
cells were handled in the same conditions without being
irradiated. Following irradiation, cells were maintained
in the Tri-Gas Incubator (2 % O2) in fresh Growth
Medium previously balanced with 2 % O2 for further
cell survival experiments.
Irradiation of 3DCM was performed as follows: the 96-
well plates containing the 3DCM were sealed with parafilm
in order to maintain 2 % O2 tension during irradiation and
put on the horizontal plate within the X-ray generator
(Fig. 2a). Mock-irradiated cells were handled in the same
conditions without being irradiated. Following irradiation,
medium was changed. Samples were collected at different
time points, rinsed once in Dulbeccos’s PBS then stored ei-
ther at −80 °C for western blot analysis or formalin-fixed
for immunohistochemistry-paraffin (IHC-p). Culture super-
natant (100 μL) was also collected and stored at −80 °C for
cell toxicity assay.
High-LET irradiation
High-LET radiation exposure was performed using the
D1 IRABAT high-energy scanning beam line at the
Grand Accélérateur National d’Ions Lourds (GANIL,
Caen, France). The dosimetry and calibration beam was
done by CIMAP (Centre de Recherche sur les Ions, les
Matériaux et la Photonique) as previously described
[22, 23]. Accelerated 18O ions (50 MeV/a, < 0.1 nA)
were used at a dose rate of ~1 Gy/min which corre-
sponded to a mean fluency of 1.22 × 105 ions/ (cm2.s).
A minimum of 30 s irradiation time was used in order to
ensure a homogeneous dose on each sample. Except for
survival curves, 2 Gy dose was used for all the samples.
Irradiation of 2D cells was performed as follows: cells
were prepared similarly to X-ray irradiation protocol
(see above). Subconfluent adherent cells were irradiated
in an upright position at Room Temperature (Fig. 2b).
Control flasks were mock-irradiated. Following irradi-
ation, cells were maintained in the Tri-Gas Incubator
(2 % O2) in fresh Growth Medium previously balanced
with 2 % O2 for further cell survival experiments.
3DCM were maintained in a vertical position in a 2 mL
polypropylene tube (Eppendorf®), with a sterile sample
holder consisting of a glass cylinder as shown in Fig. 2b.
The tube was filled with 3D Chondrocyte Medium previ-
ously balanced with 2 % O2 and irradiated in an upright
position. In this configuration, collagen scaffolds are laid-
out against the polypropylene tube thanks to the sample
holder. Following irradiation, medium was changed and
samples collected similarly to low-LET irradiated samples.
LET distribution profile in the collagen scaffold
The assessment of the LET distribution profile for 18O
ions is only available through a calculation code, based
on the Monte-Carlo method, which simulates the trans-
port of particles and their interactions into matter. Two
calculation codes were used, with the appropriate de-
scription of heavy ion physics: FLUKA (FLUktuierende
KAskade) [24, 25] from CERN (European Organization
for Nuclear Research) and INFN (Istituto Nazionale di
Fig. 1 Homogenous cell distribution in the 3D scaffold. Top: A representative image of a paraffin-embedded, HES colored 8 μm section of a
3DCM. Bottom: Magnified images (from top image) corresponding to the proximal (left), internal (middle) and distal (right) zones of the scaffold.
The collagen fibers are colored in pale red and the cells, indicated with dotted arrows, in violet
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Fisica Nucleare) and PHITS (Particle and Heavy Ion
Transport code System) [26] from JAERI (Japan Atomic
Energy Research Institute). The irradiation beam line
IRABAT was modelized, with its main features, such as
splitter; iron window to produce X-rays for fluence esti-
mation; mylar, gold and aluminium foils for ion distribu-
tion. A particular attention has been paid to reproduce
the 3DCM configuration for the ion irradiation: polypro-
pylene tube, curvature of the samples and holder pos-
ition as shown in Fig. 3a and b. The same geometry was
used for both Monte-Carlo codes. Energy cut-off, i.e.
minimum energy for which a particle is tracked, was set
to 1 keV. The LET distribution was calculated on the
front side of the model (called proximal), on its rear side
(called distal) and into the 3DCM model. In this study,
only the LET distribution of incident ions was calcu-
lated. The LET from other particles, such as alpha parti-
cles, protons, delta electrons, fragmentation nuclei, were
not calculated. Further calculations will be performed to
determine the contribution of these particles [27] to the
total dose into the 3DCM model.
CFE: Colony Forming Efficiency (2D culture)
Clonogenic assessment in 2D was done by colony form-
ing efficiency assay as previously described [28, 29]. Sub-
confluent 2D cells were irradiated as described above.
The cells were left untreated from 12 to 16 h post-
irradiation, then trypsinized, counted and plated in six-
well plates (BD Falcon™) at two densities (100 or 1000
cells). The cells were grown for 12 days without medium
Fig. 2 Schematic representation of the irradiation set-up for 2D cells and 3DCM. Panel a: X-rays irradiation set-up. Panel b: heavy ions
irradiation set-up
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change, then fixed and stained with crystal violet
(3 % w/v in 20 % ethanol solution). Only colonies of 50
cells or more were scored. The experimental survival
curve data were fitted to the linear quadratic equation
[29]: − Ln (S) = αD+ βD2. S is the surviving fraction at a
given dose D. This calculation takes into account the
mock-irradiated condition. α and β are constants deter-
mined by fitting the data to the model using the nonlin-
ear regression program of the Prism software package
(Graphpad Software, San Diego, CA). D10 (lethal dose
for 10 % survival), D37 (lethal dose for 37 % survival)
and SF2 (surviving fraction after a 2 Gy irradiation)
values were determined from the fitted curve. Experi-
ments were performed in triplicate and repeated from
2 to 6 times according to beam time availability. α
and β are expressed as mean ± S.E.M.
Canonical Relative Biological Effectiveness (RBE) was
calculated by dividing D10 of low-LET radiation by the
corresponding parameter following high-LET irradiation.
RBE was also calculated using D37.
Cell toxicity assay
Cell toxicity was assessed on 3DCM culture medium using
Toxilight™, a bioluminescent cytotoxicity assay designed to
quantitatively measure the release of Adenylate Kinase
(AK) from damaged cells. Manufacturer’s instructions
were followed. Briefly, in a 96-white well plate (Greiner
bio-one®), 20 μL of thawed cell culture supernatants were
mixed to 100 μL/well of freshly prepared AK working solu-
tion. Plates were incubated for 5 min at room temperature
before measurement. Flexstation 3 (Molecular Devices,
Sunnyvale, USA) at the Proteogen plateform of Université
Caen Basse-Normandie (UCBN) was used and pro-
grammed to 1 s integrated reading of appropriate wells.
Digitonin detergent was used as a positive control (65 pM)
as recommended by the manufacturer. Data were collected
in RLU (Relative Light Unit).
Immunohistochemistry-paraffin (IHC-p) staining
Formalin fixed 3DCM underwent a classical immuno-
histochemistry protocol (for paraffin sections), but
manually performed to maintain scaffold integrity and
avoid material loss. 3DCM were dehydrated in a graded
series of ethanol on the first day and paraffin-soaked
overnight. They were then paraffin-embedded in an up-
right position at the Pathology department of the CLCC
François Baclesse. Eight μm sections were cut with a
microtome and mounted on Superfrost™ Plus micro-
scope slides, precisely, to avoid counting the same cells.
The slides were dried overnight at 37 °C and stored at
room temperature.
Fig. 3 3DCM and polypropylene tube geometry used for FLUKA and PHITS calculations. Polypropylene tube (brown), curvature of the samples
(light green) and holder positions (blue) were taken into account to reproduce the 3DCM configuration for the ion irradiation. Culture medium
(mentioned as “serum”) is represented in yellow. Cross- (ZX, panel a) and longitudinal sections (XY, panel b) are represented
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IHC staining was carried out overnight in a humidi-
fied chamber using monoclonal antibody directed
against Ki67 diluted to 1/100 in 1 % BSA (Bovine Serum
Albumin) in 0.5 % Tween PBS (TPBS). Then, 1 h incu-
bation with HRP-conjugated anti-rabbit secondary anti-
body (diluted to 1/100 in 1 % BSA in TPBS) was done.
Sections were then revealed with DAB and mounted
using Eukitt mounting medium. No antigen retrieval
was performed and as control, a slide without primary
antibody incubation was realized.
The slides were observed with a Vanox-S Olympus
light microscope (Tokyo, Japan) using a 40x lens. For
each time point, around 200 nuclei were counted by
the same experimenter, choosing 2 to 3 fields per
slide (on a total of 5–10 slides). Only clearly stained
cells were scored as DAB positives. Mock-irradiated
sample is expressed as mean ± S.E.M from two inde-
pendent experiments.
HES (Hematoxylin, Erythrosine, Safran) classical
staining was also used to assess general organization of
the collagen scaffold and cell distribution. Image acqui-
sition was achieved, either with a Nikon Coolscope
scanner (Tokyo, Japan) at the Pathology department of
CLCC François Baclesse or Aperio Scancope CS scan-
ner (Leica biosystems, Nussloch, Germany) at HIQ pla-
teform of UCBN (Caen, France). Representative images
were shown in the figures.
Cell lysis protocol and western blotting
3DCM were disrupted using the following cell lysis proto-
col at 4 °C. Glass beads of 100 μm diameter (25 mg, Dom-
inique Dutcher, Brumath, France) were added to a round-
bottomed 2 mL Eppendorf tube and mixed with 40 μL of
a freshly prepared lysis buffer [T-PER (1 mL), NaCl
(850 mM), Halt Protease Inhibitors Cocktail (2X v/v),
EDTA (2X v/v), Halt Phosphatase Inhibitors single-use
Cocktail (2X v/v)]. One sample was then quickly thawed
and mixed with lysis buffer and glass beads at 4 °C for
15 min using a disruptor GENIE™ (Dominique Dutcher).
This cell lysis step was followed by addition of 10 μL
Laemmli buffer (5X) and 5 min mix in the disruptor, to
extract the proteins of the sample. This was followed by a
protein denaturation step (sample heated twice at 100 °C
for 5 min). After a quick centrifugation, 40 μL of the
supernatant were collected. The sample underwent a sec-
ond cycle of protein extraction-denaturation and 10 μL of
extract were collected again. To estimate an extraction
yield, the above protocol was performed twice on the same
test sample, and the ratio of both extracts was calculated
using ECL signal (the yield is expressed as mean ± S.E.M
from two experiments).
Half of the extracted sample (25 μL) underwent SDS-
Poly-Acrylamide 10 % Gel Electrophoresis (SDS-PAGE)
and was transferred to a nitrocellulose membrane.
Membranes were blocked for 1 h in 5 % milk in 0.05 %
tween-TBS (TTBS) and incubated overnight at 4 °C with
anti-H2AX phospho-serine 139 (gamma-H2AX) or anti-
GAPDH as a loading control, both diluted at 1/1000 in
1 % milk TTBS. Membranes were then incubated for
1 h at room temperature with anti-mouse secondary
peroxidase-conjugated antibodies (1/5000 diluted in 1 %
milk TTBS). Detections were assessed on X-ray films (GE
healthcare) using the ECL method. Image J software was
used to quantify the non-saturated signals. Data were
expressed as relative amount of gamma-H2AX compared
to GAPDH. Evaluation of RBE (ERBE) was expressed as the
relative amount of gamma-H2AX protein following high-
LET irradiation divided by the same parameter post low-
LET irradiation at the same time point.
Cell lysis and protein extraction using 2D cells were
performed as described for 3DCM. Cell counting was
used to adjust lysis and Laemmli buffer volumes.
Around 0.25 million cells per sample were used to per-
form the western blot.
Results and discussion
SW1353 cells characterization
The therapeutic use of hadrons has mainly focused on
low- and intermediate-grade CHS [2]. In this study, we
focused on intermediate-grade (II) CHS as they show
relative radioresistance to photons, a metastatic potential
and high recurrence rate but still maintain a cartilage
phenotype [30]. SW1353, JJ012 and CH3573 are cur-
rently the most characterized conventional grade-II CHS
cell lines [31]. Among them, SW1353 is the most exten-
sively used and is considered as the gold standard
among other cells. Indeed, 142 articles were found in
Pubmed library: [SW1353 OR HTB-94] compared to 39
articles for [JJ012] or 1 article for [CH3573]).
SW1353 cells were adapted from DMEM to a full
standardized medium then amplified in a standard cell
incubator (20 % O2 tension, normoxia). However, 3DCM
were cultivated under 2 % oxygen tension in order to
mimic human in situ microenvironment for cartilage
[16, 17]. Such condition, referred here as physioxia, was
then applied to 2D irradiations or experimental assays.
Untreated SW1353 cells in 2D culture show a doubling
time of 23 h and a usual cell cycle distribution with
42.2 % (±0.9), 35.2 % (±1.2) and 22.5 % (±0.8) of cells
collected in G0/G1, S-phase and G2/M phase’s, respect-
ively (Additional file 1: Figure S1).
3DCM were prepared by seeding 4 × 105 cells in
each scaffold and culturing them 7 days in physioxia
as described before [15]. After 7 days of maturation,
about 1.5 × 105 of the seeded cells did not attach
into the scaffold and were discarded by PBS washing.
Cell distribution of attached cells throughout the
scaffold was then analyzed. A representative image of
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a paraffin-embedded, transversally cut, HES colored
slide of a 3DCM is shown in Fig. 1. The three mag-
nified images (bottom) showed a homogenous cell
distribution in the proximal (bottom, left), internal
(bottom, middle) and distal (bottom, right) zones of
the scaffold (Fig. 1). This was comparable with the
cell distribution observed in 3DCaM seeded with AC
using Scanning Electron Microscopy [15] or IHC and
light microscopy [18]. Grade II CHS as SW1353 cell
line show poor cellularity in histological sections [4].
Thus, under cell culture conditions described here,
we were able to grow a homogeneous 3DCM miming
an intermediate grade CHS tissue cellularity.
To evaluate the proliferation ratio of SW1353 cells in
the 3DCM, we measured Ki67 index by IHC-p. Indeed,
Ki67 index was previously described as a potential
marker to assess tumor grade in CHS and determine the
prognosis of patients with grade-II CHS [32]. This end-
point was also used to evaluate the impact of different
drugs on CHS proliferation in a rat orthotopic CHS
model [33]. Cell counting was done by a single experi-
menter and to assess intra-individual variability, the
same slide was counted three times on different days
with a resulting standard deviation of 2.4 % (Table 1).
After seven days of culture into the collagen scaffold, the
proliferation index of SW1353 cell line was 33 % ± 4 %
(Table 2). This value is rather higher than the average
index previously found in a retrospective study [32] on hu-
man CHS biopsy (14.7 % ± 4.4 % for grade-II tumors), al-
though an extended custom range from 1.1 % to 50.2 %
was described [32]. These discrepancies between human in
vivo CHS and in vitro 3DCM may be explained by the cell
line used but also by biopsy undefined genetic background
and/or IHC technical issues. Furthermore, using primary
human AC from two healthy male donors (38 and 51 years
old), with non-apparent pathology, we prepared 3DCaM
[15] with the same protocol described for the 3DCM. In
comparison to 3DCM, a 2-fold inferior mean proliferation
index was measured (17.5 % ± 4.5 %) in our conditions
(Table 3). Such difference of proliferation indexes of pri-
mary chondrocytes and CHS cell line is consistent with
human cartilage physiology [14, 16].
Irradiation set up, dosimetry and LET distribution
X-rays clonogenic assay experiments were performed with
a 225 kV irradiator and a 15 MeV accelerator. Survival
curve characteristics were almost identical with both de-
vices (standard deviation < 10 %), a result which was previ-
ously described with different cell lines [34]. Subsequently,
collected data were pooled. As X-rays beams were verti-
cal, 2D culture flasks and 3DCM culture plates were
maintained horizontal (Fig. 2a). On the contrary, heavy
ion scanning beam from IRABAT line (GANIL) is hori-
zontal (Fig. 2b). Thus, 2D culture flasks and tubes bear-
ing 3DCM were then maintained in an upright position
(Fig. 2b). However, in both conditions, flasks and
3DCM were fully filled with medium and irradiated in
physioxia. Except for survival curves, SW1353 cells as
2D cultures or 3DCM were irradiated with 2 Gy of ei-
ther X-rays (low-LET) or 18O ions (high-LET) radi-
ation. These two conditions were chosen to mimic a
canonical fraction of conventional radiotherapy (low-
LET) versus a fraction of hadron-therapy with carbon
ions (high-LET). Indeed, the LET of 18O accelerated
ions (50 MeV/a) used in this study is approximatively of
103 ± 4 keV/μm which is comparable to the LET of
SOBP of a carbon ions therapeutic beam [19].
Unlike X-rays, heavy-ions have a rapid energy depos-
ition profile at the end of the track (Bragg peak). Calcu-
lations of the LET of 18O ions (50 MeV/a) for the
proximal and distal zones and into the 3DCM were per-
formed using FLUKA and PHITS calculation codes as
described above. The corresponding values, shown in
Table 4, are expressed as mean ± standard error. Using
FLUKA, the calculated LET in the proximal and distal
zones were 85.91 ± 0.38 and 109.82 ± 0.57 keV/μm, re-
spectively. Using PHITS, the LET values of 96.27 ± 0.32
and 122.97 ± 0.67 keV/μm were calculated in the prox-
imal and distal parts, respectively. These data reveal a
difference of around 17 % between these two zones, re-
gardless of the calculation method. Such variability is
not surprising, considering the collagen scaffold thick-
ness (2 mm). In addition, the proximal/distal LET distri-
bution profile, shown in Fig. 4a and b, is also related to
Table 1 Evaluation of the intra-individual counting variability of
the Ki67 proliferation index in the 3DCM
Counting Ki67 index (%) Standard deviation (%)
Day 1 28.3 2.4
Day 2 33.1
Day 3 30.8
Table 2 Ki67 proliferation index (%) 96 and 168 h following
low-LET or high-LET irradiation
Radiation
quality
Time post-irradiation (hrs)
0 96 168
Low-LET 33 ± 4 21 27
High-LET 45 43
Table 3 Ki67 proliferation index (%) in the 3DCaM using two
healthy male donnors
Ki67 proliferation index in the 3DCaM
Donnor 1 (38 years old) 13.0
Donnor 2 (51 years old) 22.0
Mean ± S.E.M 17.5 ± 4.5
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the curvature of the 3DCM set by the holder, which is
used to maintain the scaffold in an upright position
(Fig. 2b, Fig. 3a and b). This curvature has led to a vari-
ation in the thickness of 3DCM related to path of the
incident ions. However, despite the scaffold thickness
and irradiation geometry, only 17 % difference in LET
was observed between front and rear sides of the
3DCM. These distribution profiles for the proximal and
distal zones were not observed with a simulated flat geom-
etry (not shown here). Moreover, as shown in Table 4, the
mean LET into the 3DCM is 99.87 ± 0.21 keV/μm (range
85–120 keV/μm) using FLUKA, and 107.24 ± 0.11 keV/μm
(range 95–135 keV/μm) using PHITS. Taken together,
these simulation data show that cells are homogeneously
irradiated by oxygen ions in this collagen scaffold, taking
into account our irradiation geometry.
Cell survival and proliferation post-irradiation
First, we estimated the clonogenic capacities (CFE) of
SW1353 cells in standard 2D culture conditions (Table 5
and Additional file 2: Figure S2), as canonically performed
in radiation-biology studies [35]. Exposure of 2D cells to
low-LET and high-LET radiations revealed characteristic
surviving fractions (Table 5). The low-LET survival param-
eters followed the two-hit target linear quadratic model
(Additional file 2: Figure S2). In contrast, high-LET sur-
vival curves followed the one-hit target linear quadratic
model (β = 0) (Additional file 2: Figure S2). As shown in
Table 4 LET values of 18O ions in the proximal and distal zones
and into the 3DCM
Calculation
code
LET (keV/μm)
Proximal zone Into the 3DCM Distal zone
FLUKA 85.91 ± 0.38 99.87 ± 0.21 109.82 ± 0.57
PHITS 96.27 ± 0.32 107.24 ± 0.11 122.97 ± 0.67
Fig. 4 LET distribution profile of 18O ions in the proximal and distal zones of the 3DCM. FLUKA (panel a) and PHITS (panel b) calculation methods
were used
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Table 5, the value of α-component was higher with high-
LET irradiation (2.567 ± 0.217 Gy−1) compared to low-
LET irradiation (0.145 ± 0.005 Gy−1), both with a satisfying
goodness of fit (R2 = 0.900 and R2 = 0.804, respectively).
Extrapolated D10, D37 and SF2 were respectively 6.2 Gy,
3.6 Gy and 64.6 % for X-rays, and 0.9 Gy, 0.4 Gy and less
than 1 % for 18O ions. Thus, not surprisingly, SW1353 in
2D culture were more resistant to low-LET radiation
compared to high-LET. Canonical RBE calculation of 18O
ions survival relative to X-rays (2D culture) shows a ratio
of 6.8 (D10) whereas the ratio reach 9 when RBE is calcu-
lated from D37 (Table 5). These RBE values are concord-
ant with a previous review of biological effectiveness of
high-LET charged particles [19], considering a LET of
103 ± 4 keV/μm.
Clonogenic capacities were not feasible using the
3DCM, so to estimate cellular characteristics within this
model, cell death and proliferation were measured using
adapted experimental strategies. Indeed, combined
treatment of the mature 3DCM with collagenase and
Accutase™ or trypsine did not allow cell extraction in
order to perform clonogenic assay. Chondrosarcoma
cell lines are known for producing extracellular matrix
[7] which may explain the difficulty in extracting them
from the scaffold. Cell death of SW1353 in 3DCM fol-
lowing irradiation was then assessed with the Toxilight™
cytotoxicity assay as described above. The viable cell
fraction was estimated using the ratio of luminescence
produced by irradiated sample relative to mock-irradiated
sample. We do not highlight any cellular toxicity induc-
tion 48 or 96 h following a 2 Gy irradiation in the 3DCM
(ratio from 0.9 to 1.0), regardless of the radiation quality
(low- or high-LET), while ratio from 65 pM digitonin
treatment used as positive control scored 5.5 (Table 6).
Proliferation index of SW1353 in 3DCM was mea-
sured by scoring Ki67 positive cells, as described above
(Fig. 5, Table 2). The expression of human Ki67 protein
is strictly associated with cell proliferation, present dur-
ing all active phases of the cell cycle (G1, S, G2 and
mitosis) but absent from quiescent cells (G0) [36]. How-
ever, it reflects the potential of cells to divide, but does
not predict the actual division of these cells [37]. After
2 Gy of low- or high-LET radiation, this index was
scored at day 4 and 7. We observed proliferation in-
dexes of 21 % and 27 % in case of low-LET radiation,
and 45 % and 43 % in case of high-LET, respectively
(Table 1). This difference of proliferation index after
low- or high-LET radiations may be explained by a
higher number of cells arrested into the cell cycle (posi-
tive Ki67-cells arrested in G1, S, G2 or M phases) be-
cause of unrepaired clustered DNA damages. However,
although these experiments will need to be deepened,
we can hypothesize that there is still a fraction of cells
in the irradiated 3DCM with a division potential. In-
deed, it has been shown in vivo that such fraction of
CHS cells in a quiescent step may contribute to the rela-
tive radioresistance of CHS to low-LET radiations [4].
Post-irradiation gamma-H2AX repair kinetic
Reproducible and effective protein extraction from the
3DCM was a technical challenge, as cellular protein ex-
traction from collagen scaffold was not efficient using a
standard protocol. Thus, we developed a new protocol
using a cell disruptor system and specific glass beads, as
described above. This protocol allows us to calculate an
extraction yield of 94 % (±4 %) from the quantification
of western blot signal, showing the reproducibility and
capacity of our protocol to extract and analyze low
abundant proteins.
The phosphorylated form of the histone H2AX
(gamma-H2AX) is implicated in the DSB signaling and
repair processes specially after IR exposure [38, 39].
H2AX phosphorylation was thereby chosen to estimate
post-irradiation repair kinetic of SW1353 cells in the
3DCM. To do so, western blot was performed on 3DCM
following 1 h to 96 h of a 2 Gy dose of low- or high-
LET radiation (Fig. 6 and Additional file 3: Figure S3).
The gamma-H2AX positive probing (15 kD), was mea-
sured with a modulated intensity throughout the kinetic.
Using GAPDH as loading control (Fig. 6a), we measured
a 4-fold gamma-H2AX induction with low-LET radi-
ation, 1 h post-irradiation compared to mock-irradiated
sample in 3DCM (Fig. 6b). However, following this in-
duction, low-LET irradiated samples display a decrease
in gamma-H2AX expression and regain mock-irradiated
level 6 h post-exposure. Such data show that low-LET in-
duced DNA strand breaks seem to be repaired quickly in
Table 6 Cellular toxicity assay in 3DCM models following
irradiation or digitonin treatment
Mock
(RLU)
Treated
(RLU)
Ratio of luminescence relative to
mock-treated sample
Digitonin
65 pM
4864 26490 5.5
Low-LET 7531 7193 1.0
High-LET 3313 2891 0.9
Table 5 Radiation survival curve characteristics for SW1353 cells cultured in 2D
Radiation quality Energy LET (keV/μm) α (Gy−1) β (Gy−2) R2 D10 (Gy) RBE10 D37 (Gy) RBE37 SF2 (%)
X-rays 15 MeV 225 kV ~1 0.145 ± 0.036 0.037 ± 0.005 0.900 6.2 / 3.6 / 64.6
18O ion 50 MeV/a 103 ± 4 2.567 ± 0.217 0 0.804 0.9 6.8 0.4 9 <1
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3DCM as previously described for 2D cell culture [38].
Proliferation-associated gamma-H2AX phosphorylation
may explain the second wave of gamma-H2AX induction
between 12 h and 72 h after low-LET exposure [40, 41].
On the contrary, following high-LET irradiation,
gamma-H2AX induction still increases after 1 h post-
irradiation to reach a maximal at 12 h with a 10-fold
induction compared to the mock-irradiated sample
(Fig. 6b). The gamma-H2AX expression then decreases
slowly. This higher induction could be explained by the
fact that high-LET radiations trigger more complex DNA
damages that are harder to repair, compared to low-LET
radiation as it has been already shown [42–44]. However,
with 3DCM we show here that such higher gamma-H2AX
Fig. 5 Ki67 immunostaining in the 3DCM. A representative cross-section of IHC-p stained 3DCM, using an antibody directed against Ki67 protein.
Positive cells are indicated with red dotted arrows and negative cells with black dotted arrows. Counting positive cells served to assess
proliferation index in the 3DCM
Fig. 6 Post-irradiation gamma-H2AX repair kinetic in the 3DCM. Panel a: western blot analysis of gamma-H2AX, from 1 to 96 h following a 2 Gy
low-LET or high-LET irradiation. GAPDH was used as a loading control. b Gamma-H2AX signal quantification normalized to GAPDH following a
2 Gy low-LET or high-LET irradiation. Image J software was used to analyze non-saturated signals. The non-cropped images are available in
Additional file 3: Figure S3
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induction is wider, meaning probably a delayed DNA re-
pair kinetic due to our physioxic cell culture conditions.
Furthermore, gamma-H2AX induction was also measured
on 2D culture conditions at the same time points post-
irradiation (Additional file 4: Figure S4 and Additional file
5: Figure S5). Using GAPDH as loading control, we mea-
sured ~ 3-fold gamma-H2AX induction with low-LET ra-
diation, 1 h post-irradiation compared to mock-
irradiated sample. Following this induction, low-LET ir-
radiated samples display a two phase decrease with a
fast first step until 3 h post-irradiation and then a slower
decrease from 6 h to 24 h (Additional file 4: Figure S4).
High-LET irradiated samples display a 3-fold gamma-
H2AX induction 1 h post-irradiation, similarly to low-
LET exposure. However, the decrease is very slow and
only partial as a 2-fold induction is still measured 96 h
after exposure (Additional file 5: Figure S5). Such delayed
gamma-H2AX induction was recently described for high-
LET radiation [45] and is consistent with well-known de-
layed DSB repair measured after high-LET exposure in 2D
cell culture [46].
Finally, we propose a new evaluation marker of bio-
logical effectiveness named Evaluation of RBE (ERBE) by
calculating the ratio of the gamma-H2AX induction fol-
lowing high-LET irradiation compared to low-LET as a
function of time. Indeed, in the present study ERBE at 12,
24 and 48 h following irradiation show a significant de-
crease as estimated respectively to 3.0, 1.5 and 1.0 in
3DCM (Fig. 6). This marker may be useful to monitor the
impact of radiation quality in 3D models for whom col-
lecting irradiated cells for canonical clonogenicity is im-
possible. Furthermore, analysis of ERBE in a time course
manner after radiation exposure may enlighten some un-
discovered aspect of tissue response to hadron-therapy,
especially for RT hypo-fractionation clinical protocols.
Conclusions
In the present study we report, for the first time, a 3D phy-
sioxic CHS model applied to radiation-biology studies. We
showed its usefulness for studying radiation quality impact
on CHS in a controlled microenvironment that mimics in
vivo tissue homeostasis after therapeutic radiation expos-
ure. LET distribution calculation demonstrated a homoge-
nously ions irradiation through the 3DCM. We describe
here differential cellular responses (proliferation, gamma-
H2AX induction kinetic) following low- versus high-LET
radiation, using the same dose (2 Gy). The discrepancies
found between 2D culture and 3DCM response to radi-
ation, especially for high-LET exposure, may be explained
by the reconstitution of a tissue-like microenvironment in
3DCM. Indeed, cells embedded in extracellular matrix
change their whole metabolism [16] and may display spe-
cific delayed response as found for gamma-H2AX induc-
tion [41, 42]. Furthermore, high-LET irradiations of
3DCM show a particular gamma-H2AX induction, higher
and longer than low-LET. Such specific pattern should be
investigated in the future as 3D models may be used to as-
sess new and more relevant indexes of radiation biological
efficiency. Indeed, our 3DCM could be used as a validation
tool for medical beams using carbon ions or protons in
order to evaluate the RBE-LET dependence and measure
the variation of RBE along the depth-dose profile of thera-
peutic proton or heavy ion beams. This issue was pointed
out to be critical, at least in proton-therapy by Britten et
al., 2013 [47].
Furthermore, the 3DCM strategy described here could
also be applied to human AC or Mesenchymal Stem
Cells (MSCs) for radiation quality impact investigations
on normal cartilage or MSCs differentiation after thera-
peutic radiation exposure as it has been previously stud-
ied for low-LET radiations [48]. Such models could also
be transplanted in nude mice, as it has been previously
performed with AC [49].
Finally, in this study, we focused on targeted effects of
IRs on CHS cultivated in 3D. However, non-targeted ef-
fects of IRs have been previously suggested to play a role
in radiation-resistance of CHS to low-LET radiations
[50]. Further studies with 3DCM using innovative tools
will help understand the radiation-resistance of CHS in
clinics [51].
Additional files
Additional figure 1: Cell cycle distribution of SW1353 cultured in
2D. Representative histogram, showing the cell cycle phases of
SW1353 cultured in 2D. G0/G1 phase is represented in blue, S phase in
green and G2/M phase in pink. Percentage of cells in each phase is also
reported. They represent the mean of four independent experiments ±
SEM. (JPEG 12 kb)
Additional figure 2: Radiation survival curve of SW1353 cultured in
2D. SW1353 cells were irradiated with the indicated doses of X-rays
(low-LET) or 18O ions (high-LET) then plated at low density, as described in
methods. The quantification of the number of formed colonies after 11 days
of incubation was used to calculate the surviving fraction relative to the
mock-irradiation sample, at each radiation dose. The curve was fitted to the
linear quadratic model. Symbols represent the mean of all replicates and
error bars represent the SEMs. (JPEG 13 kb)
Additional figure 3: Post-irradiation gamma-H2AX repair kinetic in
the 3DCM (non-cropped images). 3DCM were irradiated with a 2 Gy
dose of low- or high-LET radiation as described above. 3DCM were collected
1 to 96 h following irradiation and stored at −80 °C. Mock-irradiated sample
was treated the same way without being irradiated. The cell lysis protocol
described above was used to prepare protein extracts. Half of each extract
underwent SDS-PAGE (10 %) analysis. Low- (panels A, B) and high- (panels
C, D) LET samples were loaded on two different gels, due to the limited
number of lanes per gel. After the transfer step, membranes were cut just
above 70 kD and incubated with the corresponding antibodies. Detections
were assessed on X-ray films using two ECL reagents depending on signal
intensity and the corresponding images are represented, with the ladder
molecular weights (kD) on the right side of each image. The gamma-H2AX
antibody was first used and positive probing observed at 15 kD; panel A
(ECL classico, 30 s) and panel C (ECL classico, 30 s). The same membranes
were, then, re-incubated with anti-GAPDH antibody and the positive probing
observed between 35 kD and 40 kD: panel B (ECL classico, 30 s) and panel D
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(ECL crescendo, 5 min). The gamma-H2AX lane reappears at 15 kD due to
the use of the same anti-mouse secondary antibody. (JPEG 194 kb)
Additional figure 4: Post-irradiation gamma-H2AX repair kinetic in
2D, following low-LET irradiation. Panel A: western blot analysis of
gamma-H2AX, from 1 to 96 h following a 2 Gy low-LET irradiation. GAPDH
was used as a loading control. (B) Gamma-H2AX signal quantification
normalized to GAPDH following a 2 Gy low-LET irradiation. Image J
software was used to analyze non-saturated signals. (JPEG 38 kb)
Additional figure 5: Post-irradiation gamma-H2AX repair kinetic in
2D, following High-LET irradiation. Panel A: western blot analysis of
gamma-H2AX, from 1 to 96 h following a 2 Gy high-LET irradiation. GAPDH
was used as a loading control. (B) Gamma-H2AX signal quantification
normalized to GAPDH following a 2 Gy high-LET irradiation. Image J
software was used to analyze non-saturated signals. (JPEG 34 kb)
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